Ergotamine-derived dopamine agonists and left ventricular function in Parkinson patients: Systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking

European Journal of Echocardiography

Volumn 9, Issue 6, 2008, Pages 803-808

  Rasmussen, Vibeke Guldbrand ^a   Poulsen, Steen Hvitfeldt ^a   Dupont, Erik ^a   Østergaard, Karen ^a   Safikhany, Gholamhossein ^b   Egeblad, Henrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

Dopamine agonists; Ergolines; Fibrosis; Myocardial function

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CABERGOLINE; ERGOTAMINE; PERGOLIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; DIASTOLE; DOPAMINE AGONISTS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ERGOTAMINE; FEMALE; HEART VALVE DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 54949153818     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jen160     Document Type: Article

References (28)

1. Junghanns S, Fuhrmann JT, Simonis G, Oelwein C, Koch R, Strasser RH et al. Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. Mov Disord 2007;22:234-8.
2. Rasmussen VG, Poulsen SH, Dupont E, Ostergaard K, Safikhany G, Egeblad H. Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease. J Intern Med 2008;263:90-8.
3. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007;356:29-38.
4. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007;356:39-46.
5. Jian B, Xu J, Connolly J, Savani RC, Narula N, Liang B et al. Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 2002;161:2111-21.
6. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004;95:253-60.
7. Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin CH et al. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 1993;142:71-8.
8. Gustafsson BI, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, Solligard E et al. Long-term serotonin administration induces heart valve disease in rats. Circulation 2005;111:1517-22.
9. Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L et al. Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 2006;113:81-9.
10. Andersen NH, Poulsen SH, Helleberg K, Ivarsen P, Knudsen ST, Mogensen CE. Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance. Eur J Echocardiogr 2003;4:306-12.
11. D'Andrea A, Stisi S, Bellissimo S, Vigorito F, Scotto di UF, Tozzi N et al. Early impairment of myocardial function in systemic sclerosis: noninvasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiogr 2005;6:407-18.
12. Poulsen SH, Andersen NH, Ivarsen PI, Mogensen CE, Egeblad H. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent 'isolated' diastolic dysfunction. J Am Soc Echocardiogr 2003;16:724-31.
13. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography-from technical considerations to clinical applications. J Am Soc Echocardiogr 2007;20:234-43.
14. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 2006;47:789-93.
15. Nielsen LS, Svanegaard J, Klitgaard NA, Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 2004;6:63-70.
16. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
17. Amico AF, Lichtenberg GS, Reisner SA, Stone CK, Schwartz RG, Meltzer RS. Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J 1989;118:1259-65.
18. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
19. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-94.
20. Newman-Tancredi A, Cussac D, Quentric Y, Touzard M, Verriele L, Carpentier N et al. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes. J Pharmacol Exp Ther 2002;303:815-22.
21. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM et al. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation 2006;113:1597-604.
22. Nikitin NP, Witte KK, Thackray SD, de SR, Clark AL, Cleland JG. Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr 2003;16:906-21.
23. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000;15:264-72.
24. Vinereanu D, Ionescu AA, Fraser AG. Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart 2001;85:30-6.
25. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granerus AK. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord 2003;18:1312-6.
26. Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort. Mov Disord 2004;19:49-53.
27. Zesiewicz TA, Strom JA, Borenstein AR, Hauser RA, Cimino CR, Fontanet HL et al. Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey. Parkinsonism Relat Disord 2004;10:417-20.
28. McCulloch M, Zoghbi WA, Davis R, Thomas C, Dokainish H. Color tissue Doppler myocardial velocities consistently underestimate spectral tissue Doppler velocities: impact on calculation peak transmitral pulsed Doppler velocity/early diastolic tissue Doppler velocity (E/Ea). J Am Soc Echocardiogr 2006;19:744-8.